$KIN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kindred Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Kindred Biosciences, Inc.. Get notifications about new insider transactions in Kindred Biosciences, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2016 | KIN | Kindred Bioscience ... | MONTGOMERY HERBERT D | Director | Option Exercise | A | 4.14 | 3,350 | 13,869 | 3,350 | |
| Apr 07 2016 | KIN | Kindred Bioscience ... | Bevers Denise | Chief Operating Off ... | Option Exercise | A | 3.60 | 30,000 | 108,000 | 30,000 | |
| Mar 17 2016 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | P | 3.55 | 30,000 | 106,500 | 99,583 | 69.6 K to 99.6 K (+43.11 %) |
| Apr 15 2016 | KIN | Kindred Bioscience ... | MONTGOMERY HERBERT D | Director | Option Exercise | A | 3.52 | 27,500 | 96,800 | 27,500 | |
| Jan 12 2016 | KIN | Kindred Bioscience ... | Chin Richard | President & CEO | Option Exercise | A | 3.45 | 197,771 | 682,310 | 197,771 | |
| Jan 12 2016 | KIN | Kindred Bioscience ... | Bevers Denise | Chief Operating Off ... | Option Exercise | A | 3.45 | 59,031 | 203,657 | 59,031 | |
| Jan 12 2016 | KIN | Kindred Bioscience ... | Sundlof Stephen | CSO and Executive V ... | Option Exercise | A | 3.45 | 59,031 | 203,657 | 59,031 | |
| Jan 12 2016 | KIN | Kindred Bioscience ... | Veszpremi Ervin | Director | Option Exercise | A | 3.45 | 44,000 | 151,800 | 44,000 | |
| Jan 12 2016 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | A | 3.45 | 44,000 | 151,800 | 44,000 | |
| Jan 12 2016 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Option Exercise | A | 3.45 | 44,000 | 151,800 | 44,000 | |
| Nov 24 2015 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Buy | P | 4.00 | 2,000 | 8,000 | 12,000 | 10 K to 12 K (+20.00 %) |
| Nov 19 2015 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Buy | P | 4.78 | 2,323 | 11,104 | 10,000 | 7.7 K to 10 K (+30.26 %) |
| Sep 01 2015 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Buy | P | 5.85 | 1,675 | 9,799 | 7,677 | 6 K to 7.7 K (+27.91 %) |
| Sep 01 2015 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Buy | P | 5.85 | 2 | 12 | 6,002 | 6 K to 6 K (+0.03 %) |
| Aug 17 2015 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Buy | P | 6.04 | 3,000 | 18,117 | 6,000 | 3 K to 6 K (+100.00 %) |
| Jun 04 2015 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | M | 1.37 | 8,750 | 11,988 | 11,250 | |
| Jun 04 2015 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | M | 0.32 | 8,333 | 2,667 | 14,167 | |
| Jun 04 2015 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | M | 1.37 | 8,750 | 11,988 | 69,583 | 60.8 K to 69.6 K (+14.38 %) |
| Jun 04 2015 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | M | 0.32 | 8,333 | 2,667 | 60,833 | 52.5 K to 60.8 K (+15.87 %) |
| Feb 06 2015 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Option Exercise | A | 6.45 | 197,771 | 1,275,623 | 197,771 | |
| Jan 28 2015 | KIN | Kindred Bioscience ... | Sundlof Stephen | SVP of Regulatory A ... | Option Exercise | A | 6.96 | 59,031 | 410,856 | 59,031 | |
| Jan 28 2015 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Option Exercise | A | 6.96 | 44,000 | 306,240 | 44,000 | |
| Jan 28 2015 | KIN | Kindred Bioscience ... | Veszpremi Ervin | Director | Option Exercise | A | 6.96 | 44,000 | 306,240 | 44,000 | |
| Jan 28 2015 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | A | 6.96 | 44,000 | 306,240 | 44,000 | |
| Jan 28 2015 | KIN | Kindred Bioscience ... | Bevers Denise | Chief Operating Off ... | Option Exercise | A | 6.96 | 59,031 | 410,856 | 59,031 | |
| Sep 30 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 9.56 | 55,590 | 531,424 | 614,495 | 558.9 K to 614.5 K (+9.95 %) |
| Sep 30 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 9.56 | 44,410 | 424,546 | 490,936 | 446.5 K to 490.9 K (+9.95 %) |
| Sep 03 2014 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | P | 10.55 | 10,000 | 105,493 | 52,500 | 42.5 K to 52.5 K (+23.53 %) |
| Aug 29 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 10.98 | 13,720 | 150,648 | 551,793 | 538.1 K to 551.8 K (+2.55 %) |
| Aug 29 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 10.98 | 11,280 | 123,857 | 453,638 | 442.4 K to 453.6 K (+2.55 %) |
| Aug 29 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 10.70 | 12,073 | 129,198 | 538,073 | 526 K to 538.1 K (+2.30 %) |
| Aug 29 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 10.70 | 9,927 | 106,233 | 442,358 | 432.4 K to 442.4 K (+2.30 %) |
| Aug 27 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 10.51 | 18,847 | 198,125 | 517,323 | 498.5 K to 517.3 K (+3.78 %) |
| Aug 27 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 10.51 | 15,497 | 162,909 | 441,108 | 425.6 K to 441.1 K (+3.64 %) |
| Aug 27 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 10.49 | 27,933 | 293,081 | 498,476 | 470.5 K to 498.5 K (+5.94 %) |
| Aug 27 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 10.49 | 22,967 | 240,977 | 425,611 | 402.6 K to 425.6 K (+5.70 %) |
| Aug 06 2014 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | M | 0.32 | 2,500 | 800 | 22,500 | |
| Aug 06 2014 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | M | 0.32 | 2,500 | 800 | 42,500 | 40 K to 42.5 K (+6.25 %) |
| May 23 2014 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | M | 0.32 | 2,500 | 800 | 25,000 | |
| May 23 2014 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | M | 0.32 | 2,500 | 800 | 40,000 | 37.5 K to 40 K (+6.67 %) |
| Apr 04 2014 | KIN | Kindred Bioscience ... | HAWLEY SELBY BLAKE | Chief Commercial Of ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Apr 04 2014 | KIN | Kindred Bioscience ... | HAWLEY SELBY BLAKE | Chief Commercial Of ... | Option Exercise | A | 19.96 | 100,000 | 1,996,000 | 100,000 | |
| Feb 07 2014 | KIN | Kindred Bioscience ... | Chin Richard | President & CEO | Option Exercise | A | 16.52 | 350,000 | 5,782,000 | 350,000 | |
| Feb 06 2014 | KIN | Kindred Bioscience ... | Veszpremi Ervin | Director | Option Exercise | A | 15.41 | 35,500 | 547,055 | 35,500 | |
| Feb 06 2014 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Option Exercise | A | 15.41 | 34,000 | 523,940 | 34,000 | |
| Feb 05 2014 | KIN | Kindred Bioscience ... | GALLIKER STEPHEN S | Chief Financial Off ... | Option Exercise | A | 15.41 | 50,000 | 770,500 | 50,000 | |
| Feb 05 2014 | KIN | Kindred Bioscience ... | Schultz Kevin | Chief Scientific Of ... | Option Exercise | A | 15.41 | 25,000 | 385,250 | 25,000 | |
| Feb 05 2014 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | M | 0.32 | 12,500 | 4,000 | 27,500 | |
| Feb 05 2014 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | A | 15.41 | 37,000 | 570,170 | 37,000 | |
| Feb 05 2014 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | M | 0.32 | 12,500 | 4,000 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Feb 05 2014 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Option Exercise | A | 15.41 | 35,500 | 547,055 | 35,500 | |
| Feb 05 2014 | KIN | Kindred Bioscience ... | Sundlof Stephen | SVP of Regulatory | Option Exercise | A | 15.41 | 75,000 | 1,155,750 | 75,000 | |
| Feb 05 2014 | KIN | Kindred Bioscience ... | Bevers Denise | Chief Operating Off ... | Option Exercise | A | 15.41 | 75,000 | 1,155,750 | 75,000 | |
| Dec 13 2013 | KIN | Kindred Bioscience ... | Schultz Kevin | Chief Scientific Of ... | Buy | P | 7.00 | 4,000 | 28,000 | 4,000 | 0 to 4 K |
| Dec 13 2013 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | P | 7.00 | 25,000 | 175,000 | 25,000 | 0 to 25 K |
| Dec 13 2013 | KIN | Kindred Bioscience ... | Sundlof Stephen | Senior Vice Preside ... | Buy | P | 7.00 | 1,000 | 7,000 | 1,000 | 0 to 1,000 |
| Dec 13 2013 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Option Exercise | A | 7.00 | 20,000 | 140,000 | 20,000 | |
| Dec 13 2013 | KIN | Kindred Bioscience ... | Townsend Raymond | Director | Buy | P | 7.00 | 3,000 | 21,000 | 3,000 | 0 to 3 K |
| Dec 13 2013 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Option Exercise | A | 7.00 | 20,000 | 140,000 | 20,000 | |
| Dec 13 2013 | KIN | Kindred Bioscience ... | NODELMAN OLEG | Director | Buy | P | 7.00 | 400,000 | 2,800,000 | 873,187 | 473.2 K to 873.2 K (+84.53 %) |